medlr news NCLT Approves Merger of Cohance Lifesciences with Suven Pharmaceuticals Suven Pharmaceuticals merges with Cohance Lifesciences, forming a cutting-edge CDMO platform specializing in ADCs, oligonucleotides, and small molecules.
